Research Interests
Neuromuscular ultrasound
Optoacoustic imaging
Muscular dystrophies and myopathies
Inflammatory neuropathies
Myasthenia gravis
Optoacoustic imaging
Muscular dystrophies and myopathies
Inflammatory neuropathies
Myasthenia gravis
Selected Grants
Understanding cognitive and neurological pathologies in infantile Pompe disease CNS
Clinical TrialInvestigator · Awarded by Genzyme Corporation · 2022 - 2030A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)
Clinical TrialPrincipal Investigator · Awarded by Avidity Biosciences · 2025 - 2028: An Open-label, Multicenter Study to Evaluate the Long-term Safety and Efficacy of Ulviprubart (ABC008) in Subjects Who Have Completed a Trial of Ulviprubart for the Treatment of Inclusion Body Myosi
Clinical TrialPrincipal Investigator · Awarded by Abcuro, Inc. · 2025 - 2028A Phase 2 Open-label Extension Study to Evaluate the Long-Term Safety, Tolerability, Efficacy, and Pharmacokinetics of AOC 1020 Administered Intravenously to Adult Participants with Facioscapulohumera
Clinical TrialPrincipal Investigator · Awarded by Avidity Biosciences · 2024 - 2028A Phase II/III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Determine the Efficacy and Safety of ABC008 in the Treatment of Subjects with Inclusion Body Myositis
Clinical TrialPrincipal Investigator · Awarded by Abcuro, Inc. · 2023 - 2027Development of Novel Imaging Biomarkers for use in Pediatric Facioscapulohumeral muscular dystrophy
ResearchMentor · Awarded by American Academy of Neurology · 2023 - 2026A Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of AOC 1020 Administered Intravenousl
Clinical TrialPrincipal Investigator · Awarded by Avidity Biosciences · 2023 - 20263D Shearwave Elasticity Biomarker Development for Neuromuscular Disease
ResearchCo Investigator · Awarded by National Institutes of Health · 2022 - 2026Nerve Ultrasound for Diagnosis and Prognosis of GBS
ResearchCo-Principal Investigator · Awarded by GBS/CIDP Foundation International · 2020 - 2023Neuromuscular ultrasound and electric impedance myography in CMT type 1A: a prospective longitudinal study
ResearchPrincipal Investigator · Awarded by American Neuromuscular Foundation · 2021 - 2023Electrical Impedance Myography and Muscle Ultrasound: Longitudinal Measures in Pompe Disease
Clinical TrialPrincipal Investigator · Awarded by Genzyme Corporation · 2016 - 2021Respiratory Muscle Training in Individuals With Pompe Disease
ResearchInvestigator · Awarded by National Institutes of Health · 2016 - 2019Understanding cognitive and neurological pathologies in infantile Pompe disease
Clinical TrialInvestigator · Awarded by Genzyme Corporation · 2016 - 2018Rand,multicenter,DB,placebo-controlled,parallel-group phase III study to investigate the efficacy, safety and tolerability of 2 diff doses of IgPro20(subcutaneious,Ig) for the treatment of chronic inflammatory demyelinating polyneuropathy(CIDP)
Clinical TrialPrincipal Investigator · Awarded by CSL Behring LLC · 2015 - 2017Early Rehabilitation in Critical Care-Supine Cycling and Functional Electrical Stimulation
Clinical TrialParticipating Faculty Member · Awarded by American Thoracic Society · 2014 - 2015External Relationships
- Alexion Pharmaceuticals, Inc. a subsidiary of AstraZeneca
- CAPVISION
- CSL Behring LLC
- NMD Pharma
- Takeda Pharmaceutical Co. Ltd.
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.